DOE Research Funds Left Intact

Pediatric Research Center Children's Hospital of Pittsburgh $15.0 Million Institute of Human Genomic Studies, Mt. Sinai (N.Y.) Medical Center $12.7 Million Science Facility, Oregon Health Science University $10.0 Million Cancer Research Center, Medical University of South Carolina $8.0 Million Institute of Nuclear Medicine, University of Medicine and Denistry, Newark $7.5 Million Center for advanced Microstructures, Lousiana State Universtiy $12.0 Million Center for Applied Opti

Written byDaniel Charles
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Institute of Human Genomic Studies, Mt.
Sinai (N.Y.) Medical Center
$12.7 Million

Science Facility, Oregon Health Science
University
$10.0 Million

Cancer Research Center, Medical
University of South Carolina
$8.0 Million

Institute of Nuclear Medicine, University of
Medicine and Denistry, Newark
$7.5 Million

Center for advanced Microstructures,
Lousiana State Universtiy
$12.0 Million

Center for Applied Optics, University of
Alabama at Huntsville
$10.6 Million

Barry Goldwater Center for Science and
Engineering, Arizona State University
$10.0 Million

Institute for Advanced Physics, Boston
University
$8.5 Million

Proton Beam Cancer Treatment Center,
Loma Linda (Calif.) University
$8.5 Million

Center for Automated Technology, Drexel
University
$6.5 Million

Multi-Purpose Center, Boston College
4.0 Million

Center for Physics and Environment, East
Central (Okla.) University
$4.0 Million

National Center for Chemical Research,
Columbia University
$4.0 Million

WASHINGTON-The 1988 research budget for the Department of Energy (DOE) emerged from back-room negotiations on Capitol Hill essentially intact despite $121.3 million earmarked ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies